Skip to main content

Table 1 Clinicopathological correlation of Slit3 expression in HCC patients

From: Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway

  

Slit3 overexpression (T/N)

p-value

  

low

high

Age

< 55

10

7

0.523

> = 55

10

13

Gender

Male

19

15

0.182

Female

1

5

HBV infectiona

No

3

3

1.000

Yes

15

16

Prior liver-directed treatmentsa

No

17

18

0.345

Yes

4

1

Differentiationa

Well

3

5

0.682

Moderate/Poor

11

10

Cirrhosisa

No

14

10

0.313

Yes

5

8

Tumor Size

<=5

3

9

0.048

> 5

17

11

Microvascular invasiona

No

10

13

0.741

Yes

8

7

Stagea

1 to 2

9

11

1.000

3 to 4

9

9

Distant metastasisa

No

9

12

1.000

Yes

8

9

  1. aIn some categories, the total number of patients was less than 40 due to incomplete information